FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine, namely to pharmacology, and can be used for treatment of depression-like disorders in experiment. For this purpose intraperitoneally introduced is 3-metoxythietan-1,1-dioxide or 3-(2-isoproxy-5-methyl phenoxy)thietan-1,1-dioxide or 3-phenylsulfonylthietan-1,1-dioxide one time in dose 2 or 20 mg/kg, or daily during two weeks in dose 2 mg/kg.
EFFECT: invention extends arsenal of efficient and safe medicatuions, used for correction of depressive disorders.
3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 5-BROMO-2-(THIETAN-3-YL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE DERIVATIVES, EXHIBITING ANTIDEPRESSANT ACTIVITY | 2011 |
|
RU2459818C1 |
| 1-(1,1-DIOXOTIETHAN-3-yl)-4-(2-OXO-2-PHENYLETHIL)-1,2,4-TRIAZOL-4-th BROMIDE, SHOWING ANTIDEPRESSIVE ACTIVITY | 2022 |
|
RU2785340C1 |
| 3,6,9-TRIAZATRICYCLOTETRADECANE DERIVATIVE AND USE THEREOF FOR TREATING DEPRESSION | 2019 |
|
RU2700595C1 |
| USE OF N,N"-SUBSTITUTED 3,7-DIAZABICYCLO[3_3_1]NONANES DERIVATIVES FOR DEPRESSION THERAPY | 2019 |
|
RU2726313C1 |
| ANTIDEPRESSANT FOR CORRECTION OF SIDE EFFECTS FROM NEUROLEPTICS | 2019 |
|
RU2746012C2 |
| SUBSTANCE ELICITING ANTIDEPRESSANT ACTIVITY | 2003 |
|
RU2232578C1 |
| 5-AMINO-SUBSTITUTED 3-BROMO-4-NITRO-1-(THIETAN-3-YL)-1H-PYRAZOLES EXHIBITING ANTIDEPRESSANT ACTIVITY | 2023 |
|
RU2817972C1 |
| N-MONO- AND N,N-DITHIETANE-CONTAINING 5-BROMO-2,4-DIHYDRO-1,2,4-TRIAZOL-3-ONES, EXHIBITING ANTIDEPRESSANT ACTIVITY | 2024 |
|
RU2826999C1 |
| 2-BROMO-1-(THIETANYL-3)IMIDAZOLE-4,5-DICARBOXYLIC ACID DERIVATIVES EXHIBITING ANTIDEPRESSANT ACTIVITY | 2014 |
|
RU2537948C1 |
| ANTIDEPRESSANT DRUG AND METHOD FOR PREPARING IT | 2013 |
|
RU2519759C1 |
